Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Alembic Pharmaceuticals Limited
Press Release May 30 2024
Business
May 30 2024
4 min read

Press Release May 30 2024

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 30, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Sacubitril and Valsartan Tablets, 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg.".

View Attachment